Omada Health added to ‘Tactical Outperform’ list at Evercore ISI

Evercore ISI analyst Elizabeth Anderson added Omada Health (OMDA) to the firm’s “Tactical Outperform” list as the firm updates estimates and makes several tactical calls in the Healthcare Technology & Distribution group ahead of Q3 earnings season. The firm keeps an Outperform rating and $27 price target on Omada shares.

Elevate Your Investing Strategy:

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on OMDA:

Disclaimer & DisclosureReport an Issue

Omada Health launches “Meal Map” AI-powered nutrition tool Omada Health announces analysis on weight maintenance post GLP-1 discontinuation Omada Health initiated with a Neutral at Baird Omada Health announce research on cost savings of virtual physical therapy Five new option listings and one option delisting on August 22nd

View Comments